Project Grant K01MH141271
- The National Institute of Mental Health awarded $186,839 to the Research Institute At Nationwide Children's Hospital on August 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) for a K23 career development grant supporting research into the static and dynamic neurocircuitry associated with fluctuations in non-suicidal self-injury. The award funds a longitudinal training study that will examine temporal variability in non-suicidal self-injury urges and behaviors by...
- The National Institute of Mental Health awarded the Research Institute At Nationwide Children's Hospital $169,416 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a retrospective cohort study examining suicidal thoughts and behaviors among youth victims of human trafficking. The study will identify individual, familial, community, and clinical characteristics—including mental health history, physical health conditions, and health service utilization...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $802,494 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study of cognitive disengagement syndrome as a transdiagnostic predictor of psychopathology across adolescence. The funded research extends an ongoing longitudinal study tracking 341 community-recruited adolescents (ages 10–12 years at baseline, enriched for cognitive disengagement syndrome...
- The National Institute of Mental Health awarded $195,804 to the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a project grant studying care transitions and discharge practices for clients of Assertive Community Treatment (ACT) programs. The research identifies client characteristics that predict psychiatric hospitalization risk during...
- The National Institute of Mental Health awarded The McLean Hospital Corporation $193,320 on February 18, 2026, under the Mental Health Research Grants program (CFDA 93.242, Assistance Listing) to support a K23 mentored career development award focused on online social networking mechanisms of suicide in adolescents. The award funds research establishing objective, ecologically valid assessment of interpersonal behavior in adolescents with suicidal thoughts and behaviors (STBS) through analysis...
- The National Institute of Mental Health awarded Northwestern University $188,499 under the Mental Health Research Grants program (CFDA 93.242) on July 24, 2026, to adapt digital single-session interventions for delivery by lay providers in rural high schools. The project focuses on addressing barriers to mental health care for adolescents with depression in rural communities, where internalizing problems are more prevalent yet mental health providers and treatment options are scarce. The...
- The National Institute of Mental Health awarded Children's Research Institute $654,005 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the function of paralaminar amygdala neurons from adolescence to adulthood using a mouse model. The recipient will examine how paralaminar nucleus neuronal responses change over the adolescent-to-early-adulthood transition, determine the necessity and sufficiency of these neurons in that transition, and characterize...
- The National Institute of Mental Health awarded Butler Hospital $781,566 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop RESTEPS, a suicide prevention intervention for youth with first-episode psychosis transitioning from acute care to outpatient treatment. The study addresses a critical gap: youth with first-episode psychosis face elevated suicide risk during care transitions, yet clinical trials of suicide-focused interventions routinely exclude...
- The National Institute of Mental Health awarded Rhode Island Hospital $855,638 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid Type I trial examining the effectiveness of ED_REACH, a family navigation intervention for youth discharged from emergency departments following suicide or non-suicidal self-injurious behavior evaluations. The trial will test ED_REACH (Resilience, Education, and Caregiver Help) with youth and their caregivers,...
- The National Institute of Mental Health awarded The Children's Hospital of Philadelphia Research Institute $721,440 on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the role of mitochondria in variable penetrance of schizophrenia in 22q11.2 deletion syndrome and its influence on presynaptic mechanisms of glutamate release. The award funds investigator-initiated research using induced neurons derived from patient stem cells to study how...
The National Institute of Mental Health awarded the Research Institute At Nationwide Children's Hospital $645,887 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test a clinical pathway for identifying and addressing social needs barriers to post-discharge mental health service engagement among psychiatrically hospitalized adolescents. The project, titled "Targeting Social Needs to Enhance Post-Psychiatric Hospital Care for Adolescents," will operate through July 31, 2030. Work focuses on youths ages 12 to 17 hospitalized at Nationwide Children's Hospital in Columbus, Ohio, and addresses social needs—including financial strain, housing, food, and transportation insecurity—that prevent timely follow-up outpatient mental health care. The research will assess perspectives of adolescent patients, caregivers, health system staff, leadership, and community organizations on the health system's role in addressing social needs; examine causal associations between unmet social needs and post-discharge service utilization; and apply intervention mapping to develop a clinical pathway that universally screens for and supports adolescents with unmet social needs during and immediately after psychiatric hospitalization. This award supports training and career development for Dr. Llamocca through the K01 career development mechanism, which is made for up to five-year periods with no renewal option.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $645.9k | 8/3/26 |